Pharma

BIX 2026 to explore the future of obesity treatments as full conference agenda is unveiled

BIOPLUS-INTERPHEX KOREA 2026 will bring together more than 300 companies and 90 industry experts in Seoul, with sessions spanning next-generation therapeutics, AI-driven drug development and global investment trends.

11th Edition Medical Device Project and Portfolio Management

Advancing portfolio visibility, resource optimization for strategic execution across the medical device lifecycle.

Ring-type CART Monitor Shows it Can Track Blood Pressure in AF and Heart Failure Patients

Data presented at ESC Congress 2026 indicate Sky Labs' cuffless CART device can deliver usable 24-hour blood pressure readings in patients whose irregular pulses have long made conventional cuff monitoring unreliable.

EyePoint’s DURAVYU misses first Phase 3 endpoint in wet AMD, putting focus on second trial

EyePoint says an unusual imbalance in unrelated vision loss affected LUGANO results, while secondary data point to reduced treatment burden.

Tagomics launches cfDNA platform for multi-organ drug safety monitoring

Cambridge-based precision medicine company introduces LiquiPath to support earlier detection of treatment-related toxicity across the drug development lifecycle.

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma

Advance forecasting, AI and analytics to drive strategic commercial decision-making across functions in Pharma.